Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
about
Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Two immune-enhanced molecular ...... neck squamous cell carcinoma.
@en
Two immune-enhanced molecular ...... neck squamous cell carcinoma.
@nl
type
label
Two immune-enhanced molecular ...... neck squamous cell carcinoma.
@en
Two immune-enhanced molecular ...... neck squamous cell carcinoma.
@nl
prefLabel
Two immune-enhanced molecular ...... neck squamous cell carcinoma.
@en
Two immune-enhanced molecular ...... neck squamous cell carcinoma.
@nl
P2860
P50
P1433
P1476
Two immune-enhanced molecular ...... d neck squamous cell carcinoma
@en
P2093
Huan Zhang
Qifeng Wang
P2860
P304
P356
10.1080/2162402X.2017.1392427
P577
2017-11-06T00:00:00Z